CLPTM1
Putative lipid scramblase CLPTM1
Also known as: CLPT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O96005
- Gene
- CLPTM1
- Ensembl
- ENSG00000104853
- Chromosome
- 19
- Canonical length
- 669 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
Predicted to enable GABA receptor binding activity. Predicted to be involved in regulation of T cell differentiation in thymus. Located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
669 residues, UniProt reviewed canonical sequence.
>O96005|CLPTM1
1 MAAAQEADGA RSAVVAAGGG SSGQVTSNGS IGRDPPAETQ PQNPPAQPAP NAWQVIKGVL
61 FRIFIIWAIS SWFRRGPAPQ DQAGPGGAPR VASRNLFPKD TLMNLHVYIS EHEHFTDFNA
121 TSALFWEQHD LVYGDWTSGE NSDGCYEHFA ELDIPQSVQQ NGSIYIHVYF TKSGFHPDPR
181 QKALYRRLAT VHMSRMINKY KRRRFQKTKN LLTGETEADP EMIKRAEDYG PVEVISHWHP
241 NITINIVDDH TPWVKGSVPP PLDQYVKFDA VSGDYYPIIY FNDYWNLQKD YYPINESLAS
301 LPLRVSFCPL SLWRWQLYAA QSTKSPWNFL GDELYEQSDE EQDSVKVALL ETNPYLLALT
361 IIVSIVHSVF EFLAFKNDIQ FWNSRQSLEG LSVRSVFFGV FQSFVVLLYI LDNETNFVVQ
421 VSVFIGVLID LWKITKVMDV RLDREHRVAG IFPRLSFKDK STYIESSTKV YDDMAFRYLS
481 WILFPLLGCY AVYSLLYLEH KGWYSWVLSM LYGFLLTFGF ITMTPQLFIN YKLKSVAHLP
541 WRMLTYKALN TFIDDLFAFV IKMPVMYRIG CLRDDVVFFI YLYQRWIYRV DPTRVNEFGM
601 SGEDPTAAAP VAEVPTAAGA LTPTPAPTTT TATREEASTS LPTKPTQGAS SASEPQEAPP
661 KPAEDKKKDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLPTM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 5
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 151 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 151 nTPM
- adrenal gland: 141 nTPM
- cerebral cortex: 128 nTPM
- liver: 121 nTPM
- amygdala: 113 nTPM
- hippocampal formation: 104 nTPM
Single-cell type
- syncytiotrophoblasts: 164 nCPM
- esophageal apical cells: 139 nCPM
- cytotrophoblasts: 122 nCPM
- extravillous trophoblasts: 121 nCPM
- enterocytes: 112 nCPM
- esophageal suprabasal cells: 100 nCPM
Immune cell
- non-classical monocyte: 50 nTPM
- eosinophil: 44 nTPM
- plasmacytoid DC: 39 nTPM
- intermediate monocyte: 38 nTPM
- memory CD8 T-cell: 37 nTPM
- classical monocyte: 28 nTPM
Brain region
- cerebral cortex: 186 nTPM
- midbrain: 171 nTPM
- thalamus: 171 nTPM
- medulla oblongata: 165 nTPM
- basal ganglia: 163 nTPM
- amygdala: 159 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 2.93
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CLPTM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLPTM1 as an antibody target. Whether an autoantibody or antibody against CLPTM1 could matter depends on whether native CLPTM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLPTM1 is annotated at the cell surface, where native CLPTM1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CLPTM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...